These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 21711467

  • 1. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
    Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, Bos JD, Wolkerstorfer A, van der Veen JP.
    J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
    [Abstract] [Full Text] [Related]

  • 2. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K, Malakar S, Sarma N, Banerjee U.
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [Abstract] [Full Text] [Related]

  • 3. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J, Lee JS, Hann SK, Oh SH.
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [Abstract] [Full Text] [Related]

  • 4. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P, Kijluakiat J, Korkij W, Sindhupak W.
    Acta Derm Venereol; 2008 Mar; 88(4):376-81. PubMed ID: 18709309
    [Abstract] [Full Text] [Related]

  • 5. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
    Fongers A, Wolkerstorfer A, Nieuweboer-Krobotova L, Krawczyk P, Tóth GG, van der Veen JP.
    Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
    [Abstract] [Full Text] [Related]

  • 7. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S, Chiricozzi A, Saraceno R, Schipani C, Chimenti S.
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [Abstract] [Full Text] [Related]

  • 8. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E, Antoniou C, Stratigos AJ, Stefanaki C, Katsambas AD.
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [Abstract] [Full Text] [Related]

  • 9. A review of monochromatic excimer light in vitiligo.
    Park KK, Liao W, Murase JE.
    Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S.
    J Dermatolog Treat; 2009 Sep; 20(1):14-8. PubMed ID: 18608735
    [Abstract] [Full Text] [Related]

  • 11. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
    Verhaeghe E, Lodewick E, van Geel N, Lambert J.
    Dermatology; 2011 Sep; 223(4):343-8. PubMed ID: 22269666
    [Abstract] [Full Text] [Related]

  • 12. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [Abstract] [Full Text] [Related]

  • 13. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
    Hossani-Madani A, Halder R.
    G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
    [Abstract] [Full Text] [Related]

  • 14. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
    Scherschun L, Kim JJ, Lim HW.
    J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
    Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Läuchli S.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo.
    Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A.
    Dermatol Surg; 2010 Apr; 36(4):499-505. PubMed ID: 20180833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, Ortonne JP.
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [Abstract] [Full Text] [Related]

  • 20. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P.
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.